Robert Freedman - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Mental Health, Pharmacology, Neuroscience Biology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Lewis AS, Olincy A, Buchanan RW, Kem WR, Picciotto MR, Freedman R. Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia. Schizophrenia Research. PMID 29050790 DOI: 10.1016/j.schres.2017.10.016  0.32
2017 Kem WR, Olincy A, Johnson L, Harris J, Wagner BD, Buchanan RW, Christians U, Freedman R. Pharmacokinetic Limitations on Effects of an Alpha7 Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended Release Formulation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28825423 DOI: 10.1038/npp.2017.182  0.32
2017 Gee KW, Olincy A, Kanner R, Johnson L, Hogenkamp D, Harris J, Tran M, Edmonds SA, Sauer W, Yoshimura R, Johnstone T, Freedman R. First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288. Journal of Psychopharmacology (Oxford, England). 269881117691590. PMID 28196430 DOI: 10.1177/0269881117691590  0.32
2016 Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R. Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 27565651 DOI: 10.1007/s10803-016-2890-6  0.6
2016 Freedman R. Further Investigation of Ketamine. The American Journal of Psychiatry. 173: 761-2. PMID 27477135 DOI: 10.1176/appi.ajp.2016.16050581  0.6
2016 Wasser T, Richards M, Radhakrishnan R, Freedman R. The American Journal of Psychiatry Residents' Journal: Training the Next Generation of Academic Psychiatrists. The American Journal of Psychiatry. 173: 461-4. PMID 27133407 DOI: 10.1176/appi.ajp.2015.15101267  0.6
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/j.schres.2016.04.011  0.6
2016 Freedman R, Michels R. Dissecting the Brain Mechanisms of Violence. The American Journal of Psychiatry. 173: 213-4. PMID 26926125 DOI: 10.1176/appi.ajp.2016.16010009  0.6
2016 Freedman R. Publishing what's important Acta Psychiatrica Scandinavica. 132: 417-418. DOI: 10.1111/acps.12487  0.6
2015 Ross RG, Hunter SK, Hoffman MC, McCarthy L, Chambers BM, Law AJ, Leonard S, Zerbe GO, Freedman R. Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation. The American Journal of Psychiatry. appiajp201515091188. PMID 26651393 DOI: 10.1176/appi.ajp.2015.15091188  0.6
2015 Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Radhakrishnan R. 2015 in Review. The American Journal of Psychiatry. 172: 1179-81. PMID 26619771 DOI: 10.1176/appi.ajp.2015.15091218  0.6
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/j.schres.2015.11.008  0.6
2015 Freedman R. Molecules and psychiatry. The American Journal of Psychiatry. 172: 1051. PMID 26575442 DOI: 10.1176/appi.ajp.2015.15091219  0.6
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, ... ... Freedman R, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/appi.ajp.2015.15050605  0.6
2015 Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Freedman R, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/ije/dyv136  0.6
2015 Freedman R, Ross RG. Prenatal choline and the development of schizophrenia. Shanghai Archives of Psychiatry. 27: 90-102. PMID 26120259 DOI: 10.11919/j.issn.1002-0829.215006  0.6
2015 Duan J, Sanders AR, Moy W, Drigalenko EI, Brown EC, Freda J, Leites C, Göring HH, Gejman PV. Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants. Human Molecular Genetics. 24: 4674-85. PMID 26022996 DOI: 10.1093/hmg/ddv199  0.6
2015 Ross RG, Freedman R. Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation. Schizophrenia Bulletin. 41: 824-34. PMID 25943124 DOI: 10.1093/schbul/sbv054  0.6
2015 Sinkus ML, Graw S, Freedman R, Ross RG, Lester HA, Leonard S. The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Neuropharmacology. 96: 274-88. PMID 25701707 DOI: 10.1016/j.neuropharm.2015.02.006  0.6
2015 Wu WL, Adams CE, Stevens KE, Chow KH, Freedman R, Patterson PH. The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring. Brain, Behavior, and Immunity. 46: 192-202. PMID 25683697 DOI: 10.1016/j.bbi.2015.02.005  0.6
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/j.schres.2015.01.027  0.6
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/j.schres.2014.12.016  0.6
2015 Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. The American Journal of Psychiatry. 172: 17-31. PMID 25553496 DOI: 10.1176/appi.ajp.2014.13121691  0.6
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/j.schres.2014.10.029  0.6
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/j.schres.2014.10.049  0.6
2014 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Richards M. 2014 in review. The American Journal of Psychiatry. 171: 1243-7. PMID 25756764 DOI: 10.1176/appi.ajp.2014.14091156  0.6
2014 Wang Y, Xiao C, Indersmitten T, Freedman R, Leonard S, Lester HA. The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7. The Journal of Biological Chemistry. 289: 26451-63. PMID 25056953 DOI: 10.1074/jbc.M114.582858  0.6
2014 Marder SR, Freedman R. Learning from people with schizophrenia Schizophrenia Bulletin. 40: 1185-1186. PMID 24973131 DOI: 10.1093/schbul/sbu096  0.6
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/j.psychres.2014.05.035  0.6
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/schbul/sbu064  0.6
2014 Freedman R. Computerization of the therapeutic task of working through. The American Journal of Psychiatry. 171: 388-90. PMID 24687192 DOI: 10.1176/appi.ajp.2014.14020168  0.6
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/journal.pone.0088379  0.6
2014 Kraemer HC, Freedman R. Computer AIDS for the diagnosis of anxiety and depression. The American Journal of Psychiatry. 171: 134-6. PMID 24500454 DOI: 10.1176/appi.ajp.2013.13111458  0.6
2014 Tregellas JR, Smucny J, Harris JG, Olincy A, Maharajh K, Kronberg E, Eichman LC, Lyons E, Freedman R. Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. The American Journal of Psychiatry. 171: 549-56. PMID 24435071 DOI: 10.1176/appi.ajp.2013.13070981  0.6
2014 Freedman R. α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annual Review of Medicine. 65: 245-61. PMID 24111888 DOI: 10.1146/annurev-med-092112-142937  0.6
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Vahabzadeh A. 2013 in review. The American Journal of Psychiatry. 170: 1388-92. PMID 24306335 DOI: 10.1176/appi.ajp.2013.13091260  0.6
2013 Freedman R. Searching for more effective smoking cessation treatment. The American Journal of Psychiatry. 170: 818-20. PMID 23903328 DOI: 10.1176/appi.ajp.2013.13060758  0.6
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/appi.ajp.2012.12020186  0.6
2013 van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196  0.6
2013 Sinkus ML, Adams CE, Logel J, Freedman R, Leonard S. Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia. Brain, Behavior, and Immunity. 32: 51-62. PMID 23395714 DOI: 10.1016/j.bbi.2013.01.087  0.6
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/j.biopsych.2012.12.021  0.6
2013 Ross RG, Hunter SK, McCarthy L, Beuler J, Hutchison AK, Wagner BD, Leonard S, Stevens KE, Freedman R. Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. The American Journal of Psychiatry. 170: 290-8. PMID 23318559 DOI: 10.1176/appi.ajp.2012.12070940  0.48
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Gabbard GO, Gau SS, Javitt DC, Oquendo MA, Shrout PE, Vieta E, Yager J. The initial field trials of DSM-5: new blooms and old thorns. The American Journal of Psychiatry. 170: 1-5. PMID 23288382 DOI: 10.1176/appi.ajp.2012.12091189  0.6
2013 Freedman R. James H. Scully, Jr., M.D., medical director of the American Psychiatric Association, 2003-2013 American Journal of Psychiatry. 170: 1113. DOI: 10.1176/appi.ajp.2013.13060723  0.6
2012 Fanous AH, Zhou B, Aggen SH, Bergen SE, Amdur RL, Duan J, Sanders AR, Shi J, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, ... ... Freedman R, et al. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. The American Journal of Psychiatry. 169: 1309-17. PMID 23212062 DOI: 10.1176/appi.ajp.2012.12020218  0.6
2012 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Seawell M. 2012 in review. The American Journal of Psychiatry. 169: 1233-7. PMID 23212053 DOI: 10.1176/appi.ajp.2012.12091250  0.6
2012 Freedman R. Brain development and schizophrenia. The American Journal of Psychiatry. 169: 1019-21. PMID 23032379 DOI: 10.1176/appi.ajp.2012.12081017  0.6
2012 Olincy A, Freedman R. Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Handbook of Experimental Pharmacology. 211-32. PMID 23027417 DOI: 10.1007/978-3-642-25758-2_8  0.6
2012 Hunter SK, Mendoza JH, D'Anna K, Zerbe GO, McCarthy L, Hoffman C, Freedman R, Ross RG. Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating. The American Journal of Psychiatry. 169: 616-24. PMID 22581104 DOI: 10.1176/appi.ajp.2012.11091365  0.6
2012 Stephens SH, Franks A, Berger R, Palionyte M, Fingerlin TE, Wagner B, Logel J, Olincy A, Ross RG, Freedman R, Leonard S. Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatric Genetics. 22: 1-14. PMID 21970977 DOI: 10.1097/YPG.0b013e32834c0c33  0.6
2011 Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 70: 20-33. PMID 21482353 DOI: 10.1016/j.neuron.2011.03.014  0.6
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/j.schres.2011.01.005  0.6
2011 Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, ... ... Freedman R, et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. The American Journal of Psychiatry. 168: 302-16. PMID 21285140 DOI: 10.1176/appi.ajp.2010.10060876  0.6
2011 Tregellas JR, Tanabe J, Rojas DC, Shatti S, Olincy A, Johnson L, Martin LF, Soti F, Kem WR, Leonard S, Freedman R. Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biological Psychiatry. 69: 7-11. PMID 20728875 DOI: 10.1016/j.biopsych.2010.07.004  0.6
2011 Hunter SK, Kisley MA, McCarthy L, Freedman R, Ross RG. Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use. Schizophrenia Bulletin. 37: 1200-8. PMID 20403924 DOI: 10.1093/schbul/sbq036  0.6
2010 Sanders AR, Levinson DF, Duan J, Dennis JM, Li R, Kendler KS, Rice JP, Shi J, Mowry BJ, Amin F, Silverman JM, Buccola NG, Byerley WF, Black DW, Freedman R, et al. The Internet-based MGS2 control sample: self report of mental illness. The American Journal of Psychiatry. 167: 854-65. PMID 20516154 DOI: 10.1176/appi.ajp.2010.09071050  0.6
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, ... ... Freedman R, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/j.schres.2010.03.004  0.6
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/j.1469-8986.2010.01004.x  0.6
2010 Tregellas JR, Olincy A, Johnson L, Tanabe J, Shatti S, Martin LF, Singel D, Du YP, Soti F, Kem WR, Freedman R. Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 938-42. PMID 19956085 DOI: 10.1038/npp.2009.196  0.6
2010 Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, Freedman R, Adams CE. Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 51: 535-49. PMID 19925602 DOI: 10.1111/j.1469-7610.2009.02187.x  0.6
2010 Freedman R, Goldowitz D. Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia. Progress in Neurobiology. 90: 263-75. PMID 19853005 DOI: 10.1016/j.pneurobio.2009.10.008  0.6
2009 Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, ... ... Freedman R, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 460: 753-7. PMID 19571809 DOI: 10.1038/nature08192  0.6
2009 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, Javitt DC, Leibenluft E, et al. Conflict of interest-- an issue for every psychiatrist. The American Journal of Psychiatry. 166: 274. PMID 19255048 DOI: 10.1176/appi.ajp.2009.09010093  0.6
2009 Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, Dickenson J, James B, Fingerlin TE, Wagner B, Hodgkinson C, Graw S, Ross RG, Freedman R, Leonard S. Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophrenia Research. 109: 102-12. PMID 19181484 DOI: 10.1016/j.schres.2008.12.017  0.6
2008 Simosky JK, Freedman R, Stevens KE. Olanzapine improves deficient sensory inhibition in DBA/2 mice. Brain Research. 1233: 129-36. PMID 18687314 DOI: 10.1016/j.brainres.2008.07.057  0.6
2007 Tregellas JR, Davalos DB, Rojas DC, Waldo MC, Gibson L, Wylie K, Du YP, Freedman R. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophrenia Research. 92: 262-72. PMID 17336502 DOI: 10.1016/j.schres.2006.12.033  0.6
2007 Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 611-4. PMID 17192894 DOI: 10.1002/ajmg.b.30470  0.6
2006 Tanabe J, Tregellas JR, Martin LF, Freedman R. Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia. Biological Psychiatry. 59: 754-61. PMID 16259965 DOI: 10.1016/j.biopsych.2005.09.004  0.6
2005 Tregellas JR, Tanabe JL, Martin LF, Freedman R. FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia. The American Journal of Psychiatry. 162: 391-3. PMID 15677609 DOI: 10.1176/appi.ajp.162.2.391  0.6
2004 Tregellas JR, Tanabe JL, Miller DE, Ross RG, Olincy A, Freedman R. Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study. The American Journal of Psychiatry. 161: 315-21. PMID 14754781 DOI: 10.1176/appi.ajp.161.2.315  0.6
2003 Simosky JK, Stevens KE, Adler LE, Freedman R. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology. 165: 386-96. PMID 12459928 DOI: 10.1007/s00213-002-1285-x  0.6
2002 Simosky JK, Stevens KE, Freedman R. Nicotinic agonists and psychosis. Current Drug Targets. Cns and Neurological Disorders. 1: 149-62. PMID 12769624  0.6
2002 Tregellas JR, Tanabe JL, Miller DE, Freedman R. Monitoring eye movements during fMRI tasks with echo planar images. Human Brain Mapping. 17: 237-43. PMID 12395391 DOI: 10.1002/hbm.10070  0.6
2001 Simosky JK, Stevens KE, Kem WR, Freedman R. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biological Psychiatry. 50: 493-500. PMID 11600102 DOI: 10.1016/S0006-3223(01)01093-9  0.6
Show low-probability matches.